A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML
暂无分享,去创建一个
J. Welch | R. Vij | P. Westervelt | J. Dipersio | C. Abboud | G. Uy | A. Cashen | M. Jacoby | I. Pusic | K. Stockerl-Goldstein | M. Schroeder | Haixia Niu